Ligufalimab and Cadonilimab in Advanced Liver Cancers — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ligufalimab and Cadonilimab in Advanced Liver Cancers — Stella

Recruiting

Back to Advanced Hepatocellular Carcinoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Texas Southwestern Medical Center, Dallas, Texas

Key details

Phase

Safety & dosing

Sponsor

University of Texas Southwestern Medical Center

Collaborators

Akesobio, Josephine Hughes Sterling Foundation

Enrollment target

~64 participants

Started

February 2025

Primary completion

May 2029

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov